4 studies were found.

1.		No longer recruiting	Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma Conditions: Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
2.		No longer recruiting	Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma Conditions: Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
3.		No longer recruiting	Phase II Trial of Allovectin-7® for Head and Neck Cancer Conditions: Head and Neck Cancer; Squamous Cell Carcinoma of the Oral Cavity or Oropharynx; Head and Neck Neoplasms; Carcinoma of the Head and Neck
4.		Recruiting	Phase II Trial of Allovectin-7® for Metastatic Melanoma Conditions: Melanoma; Metastatic Melanoma; Malignant Melanoma; Skin Cancer